chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Product administered to patient of inappropriate age
Clinical narrative: Minor sore arm (after 2nd dose); Nice red arm (after 2nd dose); Patient received vaccine at the age of 14; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Minor sore arm (after 2nd dose)), ERYTHEMA (Nice red arm (after 2nd dose)) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient received vaccine at the age of 14) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 55442 and 54615) for COVID-19 vaccination.     Concurrent medical conditions included ADHD. Concomitant products included DEXAMETHASONE, OFLOXACIN HYDROCHLORIDE (FOCALIN [DEXAMETHASONE;OFLOXACIN HYDROCHLORIDE]) for ADHD, GUAIFENESIN for Sleep disorder, MELATONIN for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient received vaccine at the age of 14). On an unknown date, the patient experienced PAIN IN EXTREMITY (Minor sore arm (after 2nd dose)) and ERYTHEMA (Nice red arm (after 2nd dose)). On 15-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient received vaccine at the age of 14) had resolved. At the time of the report, PAIN IN EXTREMITY (Minor sore arm (after 2nd dose)) and ERYTHEMA (Nice red arm (after 2nd dose)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications was not reported. The patient is in the TeenCOVE clinical study trial. it was reported that he  got the red arm because they were not sure if he received placebo.   This case was linked to MOD-2022-452775, MOD-2022-452102 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: high pitched ringing in the ear; This spontaneous case was reported by a non-health professional and describes the occurrence of TINNITUS (high pitched ringing in the ear) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (high pitched ringing in the ear). At the time of the report, TINNITUS (high pitched ringing in the ear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment reported   This case was linked to MOD-2022-452691 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: first shot her arm was swollen; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (first shot her arm was swollen) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 016C21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD and Degenerative disc disease.   On 23-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (first shot her arm was swollen). At the time of the report, PERIPHERAL SWELLING (first shot her arm was swollen) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       She stated that she wishes she didn't get the vaccine. Patient had many other comorbidities at baseline including degenerative disc disease.  No concomitant medication details were provided. No treatment medication details were provided.   This case was linked to MOD-2022-452853 (Patient Link).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: Received booster dose instead of the full 3rd dose.; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (Received booster dose instead of the full 3rd dose.) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033F21A and 037K20A) for COVID-19 vaccination.     Concomitant products included ADALIMUMAB (HUMIRA) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced ACCIDENTAL UNDERDOSE (Received booster dose instead of the full 3rd dose.). On 05-Nov-2021, ACCIDENTAL UNDERDOSE (Received booster dose instead of the full 3rd dose.) had resolved.            Patient is considered immunocompromise because she is taking Humira. At the time of getting the booster she did not know she should have received the full 3rd dose. When she went back to her doctor, he told her she should have received a full 3rd dose. Batch number for second dose is Lot #: 042L20A OR could be 042C20A No treatment information was provided.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: severe itching from head to toe; severe hives; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (severe itching from head to toe) and URTICARIA (severe hives) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 059H21A), 029K20A and 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 19-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced PRURITUS (severe itching from head to toe) and URTICARIA (severe hives). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (intravenous) for Adverse event, at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency; PREDNISONE for Adverse event, at an unspecified dose and frequency and EPINEPHRINE (EPIPEN) for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (severe itching from head to toe) had not resolved and URTICARIA (severe hives) outcome was unknown.            No concomitant medications were reported.  Patient has no pre-existing condition and prior allergy.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Vaccination site rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH (rashes across lower back, underside of left leg, on thigh, came back on back,rashes are on left side of body) and VACCINATION SITE RASH (Rashes appear on left side which is same side vaccine was injection into left arm) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A, 016M20A and 013LZ0A) for COVID-19 vaccination.     The patient's past medical history included Hives (Hives as a kid & whenever rashes pop up, it can happen on same area he sits.). Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), LEVOTHYROXINE SODIUM (SYNTHROID) and ZOLPIDEM for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (rashes across lower back, underside of left leg, on thigh, came back on back,rashes are on left side of body) and VACCINATION SITE RASH (Rashes appear on left side which is same side vaccine was injection into left arm). At the time of the report, RASH (rashes across lower back, underside of left leg, on thigh, came back on back,rashes are on left side of body) and VACCINATION SITE RASH (Rashes appear on left side which is same side vaccine was injection into left arm) outcome was unknown.            Treatment medication includes: Heating pads, Steroids, Topical creams It was reported that the patient visited his dermatologist who stated that Rash was related to medications.
Sex: U
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: I experienced heavy acute epistaxis. (4 in the past 3 days); This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (I experienced heavy acute epistaxis. (4 in the past 3 days)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EPISTAXIS (I experienced heavy acute epistaxis. (4 in the past 3 days)). At the time of the report, EPISTAXIS (I experienced heavy acute epistaxis. (4 in the past 3 days)) outcome was unknown. Not Provided          No concomitant and treatment drug information was provided. Patient reported that with the booster shot patient had experienced heavy acute epistaxis(4 in the past 3 days).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Oral herpes, Pain
Clinical narrative: Cold sores on her mouth and around her mouth started popping up; she got sick like sick sick; sore; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Cold sores on her mouth and around her mouth started popping up), ILLNESS (she got sick like sick sick) and PAIN (sore) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051F21A, 027L20A and 011M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jan-2022, the patient experienced ILLNESS (she got sick like sick sick) and PAIN (sore). On 14-Jan-2022, the patient experienced ORAL HERPES (Cold sores on her mouth and around her mouth started popping up). At the time of the report, ORAL HERPES (Cold sores on her mouth and around her mouth started popping up), ILLNESS (she got sick like sick sick) and PAIN (sore) outcome was unknown.            No concomitant medications were reported.  No treatment information was reported.
Age: 55.0
Sex: M
Vaccine: COVID19, UNK, UNK
Symptoms: Illness
Clinical narrative: Very ill; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very ill) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect products included non-company products TREPROSTINIL tablet, extended release for Pulmonary arterial hypertension and TREPROSTINIL DIOLAMIN (ORENITRAM) tablet, extended release for Pulmonary arterial hypertension.    Concurrent medical conditions included Pulmonary arterial hypertension. Concomitant products included APIXABAN (ELIQUIS), MACITENTAN (OPSUMIT) and RIOCIGUAT (ADEMPAS) for an unknown indication.   On 14-Oct-2021, the patient started TREPROSTINIL (Oral) 1.375 mg every eight hours and TREPROSTINIL DIOLAMIN (ORENITRAM) (Oral) .25 mg every eight hours. On 14-Oct-2021, TREPROSTINIL DIOLAMIN (ORENITRAM) (Oral) dosage was changed to 1 mg every eight hours and TREPROSTINIL DIOLAMIN (ORENITRAM) (Oral) dosage was changed to .125 mg every eight hours. On 01-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced ILLNESS (Very ill). At the time of the report, ILLNESS (Very ill) outcome was unknown. Not Provided          No treatment medication reported by reporter.  Patient was participating in a patient support program via Accredo specialty pharmacy and began therapy with Orenitram (treprostinil diethanolamine), on 14 Oct 2021 for primary pulmonary arterial hypertension. The patient was supplied with Orenitram 0.25 mg, 1 mg and 0.125 mg and the current dose was reported as 1.375 mg, oral (PO), every eight hours (q8h).  And on 01-Jan-2022, patient received Moderna booster shot.  The patient reported that he was very ill and it was touch and go for a while after the COVID booster shot.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Oral disorder
Clinical narrative: developed a bump on their face/a bump just appear on their mouth; This spontaneous case was reported by a pharmacist and describes the occurrence of ORAL DISORDER (developed a bump on their face/a bump just appear on their mouth) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ORAL DISORDER (developed a bump on their face/a bump just appear on their mouth). At the time of the report, ORAL DISORDER (developed a bump on their face/a bump just appear on their mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported .  No treatment information was provided by the reporter. On 14Jan2022 went to see an HCP because patient developed a bump on their face, a bump just appear on their mouth.    This case was linked to MOD-2022-453484 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Illness
Clinical narrative: Hot flashes/Hot flashes like menopause; Sick; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Hot flashes/Hot flashes like menopause) and ILLNESS (Sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 067F21A, 037K20A and 043L20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Acid reflux (esophageal).   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HOT FLUSH (Hot flashes/Hot flashes like menopause) and ILLNESS (Sick). At the time of the report, HOT FLUSH (Hot flashes/Hot flashes like menopause) had not resolved and ILLNESS (Sick) outcome was unknown.            Relevant concomitant medications included Acid reflux and Cholesterol medication.  Patient was sure that after the booster patient experienced these symptoms. Patient still has hot flashes couple of times a day (morning and several times in the evening).  No treatment information was provided.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (got a booster dose instead of a second dose) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jan-2022, the patient experienced INCORRECT DOSE ADMINISTERED (got a booster dose instead of a second dose). On 14-Jan-2022, INCORRECT DOSE ADMINISTERED (got a booster dose instead of a second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  Patient was scheduled for Second dose on 12Jan2022 but did not attend second dose schedule. Patient had returned to the facility and then the pharmacist wonders if they should get the patient half dose or not.   This case was linked to MOD-2022-453434 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt sick a day and a half) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. Concomitant products included ENALAPRIL for Blood pressure high, ATORVASTATIN for Cholesterol, ERGOCALCIFEROL (VITAMIN D2) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (felt sick a day and a half). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, MALAISE (felt sick a day and a half) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.Concomitant includes vitamins.This case was linked to MOD-2022-453539, MOD-2022-453540 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bedridden, Blood pressure measurement, Feeling cold, Gait inability, Heart rate
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt sick a day and a half) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. Concomitant products included ENALAPRIL for Blood pressure high, ATORVASTATIN for Cholesterol, ERGOCALCIFEROL (VITAMIN D2) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (felt sick a day and a half). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, MALAISE (felt sick a day and a half) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.Concomitant includes vitamins.This case was linked to MOD-2022-453539, MOD-2022-453540 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Hypotension, Illness, Migraine, Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt sick a day and a half) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. Concomitant products included ENALAPRIL for Blood pressure high, ATORVASTATIN for Cholesterol, ERGOCALCIFEROL (VITAMIN D2) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (felt sick a day and a half). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, MALAISE (felt sick a day and a half) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.Concomitant includes vitamins.This case was linked to MOD-2022-453539, MOD-2022-453540 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (Low blood pressure, normally is 110/60 and reached  80/50), HEART RATE INCREASED (Heart rate is normally 70 and reached 165), GAIT INABILITY (Could can hardly walk), FEELING COLD (Freezing to death) and PAIN (Aching all over,everything hurt.) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A and 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Blood pressure high and Cholesterol.Concomitant products included ENALAPRIL for Blood pressure high, ATORVASTATIN for Cholesterol, ERGOCALCIFEROL (VITAMIN D2), ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMINS NOS for an unknown indication.On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.On 30-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOTENSION (Low blood pressure, normally is 110/60 and reached  80/50), HEART RATE INCREASED (Heart rate is normally 70 and reached 165), GAIT INABILITY (Could can hardly walk), FEELING COLD (Freezing to death), PAIN (Aching all over,everything hurt.), MIGRAINE (Horrible horrible migraine headache), ILLNESS (So sick) and BEDRIDDEN (In bed for 4 days). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPOTENSION (Low blood pressure, normally is 110/60 and reached  80/50), HEART RATE INCREASED (Heart rate is normally 70 and reached 165), GAIT INABILITY (Could can hardly walk), FEELING COLD (Freezing to death), PAIN (Aching all over,everything hurt.), MIGRAINE (Horrible horrible migraine headache) and ILLNESS (So sick) outcome was unknown and BEDRIDDEN (In bed for 4 days) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available):On an unknown date, Blood pressure measurement: 80/50 (Low) normally is 110/60 and reached 80/50.On an unknown date, Heart rate: 165 (High) normally 70 and reached 165.After the second dose the patient had the events.This case was linked to MOD-2022-453520, MOD-2022-453540 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bedridden, Blood pressure measurement, Feeling cold, Gait inability, Heart rate
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (Low blood pressure, normally is 110/60 and reached  80/50), HEART RATE INCREASED (Heart rate is normally 70 and reached 165), GAIT INABILITY (Could can hardly walk), FEELING COLD (Freezing to death) and PAIN (Aching all over,everything hurt.) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A and 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Blood pressure high and Cholesterol.Concomitant products included ENALAPRIL for Blood pressure high, ATORVASTATIN for Cholesterol, ERGOCALCIFEROL (VITAMIN D2), ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMINS NOS for an unknown indication.On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.On 30-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOTENSION (Low blood pressure, normally is 110/60 and reached  80/50), HEART RATE INCREASED (Heart rate is normally 70 and reached 165), GAIT INABILITY (Could can hardly walk), FEELING COLD (Freezing to death), PAIN (Aching all over,everything hurt.), MIGRAINE (Horrible horrible migraine headache), ILLNESS (So sick) and BEDRIDDEN (In bed for 4 days). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPOTENSION (Low blood pressure, normally is 110/60 and reached  80/50), HEART RATE INCREASED (Heart rate is normally 70 and reached 165), GAIT INABILITY (Could can hardly walk), FEELING COLD (Freezing to death), PAIN (Aching all over,everything hurt.), MIGRAINE (Horrible horrible migraine headache) and ILLNESS (So sick) outcome was unknown and BEDRIDDEN (In bed for 4 days) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available):On an unknown date, Blood pressure measurement: 80/50 (Low) normally is 110/60 and reached 80/50.On an unknown date, Heart rate: 165 (High) normally 70 and reached 165.After the second dose the patient had the events.This case was linked to MOD-2022-453520, MOD-2022-453540 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Hypotension, Illness, Migraine, Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (Low blood pressure, normally is 110/60 and reached  80/50), HEART RATE INCREASED (Heart rate is normally 70 and reached 165), GAIT INABILITY (Could can hardly walk), FEELING COLD (Freezing to death) and PAIN (Aching all over,everything hurt.) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A and 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Blood pressure high and Cholesterol.Concomitant products included ENALAPRIL for Blood pressure high, ATORVASTATIN for Cholesterol, ERGOCALCIFEROL (VITAMIN D2), ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMINS NOS for an unknown indication.On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.On 30-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOTENSION (Low blood pressure, normally is 110/60 and reached  80/50), HEART RATE INCREASED (Heart rate is normally 70 and reached 165), GAIT INABILITY (Could can hardly walk), FEELING COLD (Freezing to death), PAIN (Aching all over,everything hurt.), MIGRAINE (Horrible horrible migraine headache), ILLNESS (So sick) and BEDRIDDEN (In bed for 4 days). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPOTENSION (Low blood pressure, normally is 110/60 and reached  80/50), HEART RATE INCREASED (Heart rate is normally 70 and reached 165), GAIT INABILITY (Could can hardly walk), FEELING COLD (Freezing to death), PAIN (Aching all over,everything hurt.), MIGRAINE (Horrible horrible migraine headache) and ILLNESS (So sick) outcome was unknown and BEDRIDDEN (In bed for 4 days) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available):On an unknown date, Blood pressure measurement: 80/50 (Low) normally is 110/60 and reached 80/50.On an unknown date, Heart rate: 165 (High) normally 70 and reached 165.After the second dose the patient had the events.This case was linked to MOD-2022-453520, MOD-2022-453540 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Urinary incontinence
Clinical narrative: temporaraly lost control over my bladder/peed my pants with out even knowing it or feelining it; This spontaneous case was reported by an other health care professional and describes the occurrence of URINARY INCONTINENCE (temporaraly lost control over my bladder/peed my pants with out even knowing it or feelining it) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URINARY INCONTINENCE (temporaraly lost control over my bladder/peed my pants with out even knowing it or feelining it). At the time of the report, URINARY INCONTINENCE (temporaraly lost control over my bladder/peed my pants with out even knowing it or feelining it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medication was not reported.
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of ILLNESS (sick the next day after booster dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick the next day after booster dose). At the time of the report, ILLNESS (sick the next day after booster dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.No concomitant were reported. No treatment were reported.
Sex: U
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of MIGRAINE (headaches similar to Migraines) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.On 13-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (headaches similar to Migraines). At the time of the report, MIGRAINE (headaches similar to Migraines) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Treatment information was provided.No Concomitant medication was provided.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Discomfort
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of DISCOMFORT (Little discomfort) and CHILLS (Chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2022, the patient experienced DISCOMFORT (Little discomfort) and CHILLS (Chills). At the time of the report, DISCOMFORT (Little discomfort) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was reported.  Patient did not had experienced any side effects during the day and night, but like an hour ago from reported time patient started with chills and little discomfort.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by a patient family member or friend and describes the occurrence of HEADACHE (Headache), MYALGIA (body ache), CHILLS (chills) and PYREXIA (pyrexia) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024CZ1A) for COVID-19 vaccination.     Concurrent medical conditions included Congenital hypothyroidism (By Birth.). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) from 20-Dec-2000 to an unknown date for an unknown indication.    On 10-May-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), MYALGIA (body ache), CHILLS (chills) and PYREXIA (pyrexia). At the time of the report, HEADACHE (Headache), MYALGIA (body ache), CHILLS (chills) and PYREXIA (pyrexia) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment information was not reported.   This case was linked to MOD-2022-443899, MOD-2022-452235 (Patient Link).
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by a dentist and describes the occurrence of MYALGIA (body aches) and PYREXIA (fever) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced MYALGIA (body aches) and PYREXIA (fever). On 31-Jan-2021, MYALGIA (body aches) and PYREXIA (fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not reported.  Treatment medications was not reported.   This case was linked to MOD-2022-453892 (Patient Link).
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of VISUAL IMPAIRMENT (Reduced vision), TINNITUS (Tinnitus (ringing in the ears)), DIZZINESS (Dizziness), MYALGIA (Body aches) and PYREXIA (Fever) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030H21B, 039K20A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TINNITUS (Tinnitus (ringing in the ears)). On an unknown date, the patient experienced VISUAL IMPAIRMENT (Reduced vision), DIZZINESS (Dizziness), MYALGIA (Body aches), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Persistent headaches). At the time of the report, VISUAL IMPAIRMENT (Reduced vision), DIZZINESS (Dizziness), MYALGIA (Body aches), PYREXIA (Fever) and CHILLS (Chills) had not resolved and TINNITUS (Tinnitus (ringing in the ears)) and HEADACHE (Persistent headaches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment medications were not provided.   This case was linked to MOD-2022-453877 (Patient Link).
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Visual impairment
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of VISUAL IMPAIRMENT (Reduced vision), TINNITUS (Tinnitus (ringing in the ears)), DIZZINESS (Dizziness), MYALGIA (Body aches) and PYREXIA (Fever) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030H21B, 039K20A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TINNITUS (Tinnitus (ringing in the ears)). On an unknown date, the patient experienced VISUAL IMPAIRMENT (Reduced vision), DIZZINESS (Dizziness), MYALGIA (Body aches), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Persistent headaches). At the time of the report, VISUAL IMPAIRMENT (Reduced vision), DIZZINESS (Dizziness), MYALGIA (Body aches), PYREXIA (Fever) and CHILLS (Chills) had not resolved and TINNITUS (Tinnitus (ringing in the ears)) and HEADACHE (Persistent headaches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment medications were not provided.   This case was linked to MOD-2022-453877 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Head banging, Headache
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HEAD BANGING (I feel bang in my head when I change positions like getting up from bed or standing up from a chair.) and HEADACHE (Took it Friday 14 January and 3days after am still having headache/The headache seems to be in the middle of my brain.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced HEAD BANGING (I feel bang in my head when I change positions like getting up from bed or standing up from a chair.) and HEADACHE (Took it Friday 14 January and 3days after am still having headache/The headache seems to be in the middle of my brain.). At the time of the report, HEAD BANGING (I feel bang in my head when I change positions like getting up from bed or standing up from a chair.) and HEADACHE (Took it Friday 14 January and 3days after am still having headache/The headache seems to be in the middle of my brain.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided. No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-Jan-2022: Added event verbatim. On 18-Jan-2022: Added event.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: severe soreness at the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE PAIN (severe soreness at the injection site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (severe soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (severe soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use and treatment information was not provided by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Atypical pneumonia, X-ray
Clinical narrative: walking pneumonia; This spontaneous case was reported by a consumer and describes the occurrence of ATYPICAL PNEUMONIA (walking pneumonia) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced ATYPICAL PNEUMONIA (walking pneumonia) (seriousness criterion medically significant). The patient was treated with AMOXICILLIN for Adverse event, at an unspecified dose and frequency. At the time of the report, ATYPICAL PNEUMONIA (walking pneumonia) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Dec-2021, X-ray: abnormal (abnormal) Patient was diagnosed with pneumonia..         No concomitant medication was given. On 28-Dec-2021 when patient visited the doctor it was confirmed that patient still had pneumonia and due to that doctor prescribed more medicine to her. It was reported that doctors keep changing her antibiotics as the medicine were not working. Treatment medication was mentioned as on 28-Dec-2021 patient started with steriods and took them for 5 days.  Company comment: This is a spontaneous case concerning a 73-year-old female patient with no medical history reported, who experienced serious, unexpected event of atypical pneumonia. The event occurred approximately 8 months after the administration of second dose of mRNA-1273 vaccine. It was reported that patient had been coughing for a long time. On 06-Dec-2021 an X-ray was performed and she was diagnosed with pneumonia. on 28-Dec-2021 doctors said the event was not resolved and she started steroids for 5 days. Patient said doctors kept changing her antibiotics because they weren't working. Patient only remembered amoxicillin. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a 73-year-old female patient with no medical history reported, who experienced serious, unexpected event of atypical pneumonia. The event occurred approximately 8 months after the administration of second dose of mRNA-1273 vaccine. It was reported that patient had been coughing for a long time. On 06-Dec-2021 an X-ray was performed and she was diagnosed with pneumonia. on 28-Dec-2021 doctors said the event was not resolved and she started steroids for 5 days. Patient said doctors kept changing her antibiotics because they weren't working. Patient only remembered amoxicillin. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (has covid-19  although they say they have been vaccinated) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (has covid-19  although they say they have been vaccinated). At the time of the report, COVID-19 (has covid-19  although they say they have been vaccinated) outcome was unknown.            Concomitant medication information not provided.  Treatment information not provided.  Company comment: This case concerns a patient of unknown age and gender with no medical history reported, who experienced the unexpected event of COVID 19. The event occurred after a dose of mRNA-1273. As reported, patient has covid-19  although the patient have been vaccinated. Based on the current available information, the mRNA-1273 does not contain a virus capable of causing COVID-19 infection after vaccination. The benefit-risk relationship of mRNA-1273 is not affected by this report. Event seriousness assessed as per Regulatory Authority reporting. Sender's Comments: This case concerns a patient of unknown age and gender with no medical history reported, who experienced the unexpected event of COVID 19. The event occurred after a dose of mRNA-1273. As reported, patient has covid-19  although the patient have been vaccinated. Based on the current available information, the mRNA-1273 does not contain a virus capable of causing COVID-19 infection after vaccination. The benefit-risk relationship of mRNA-1273 is not affected by this report. Event seriousness assessed as per Regulatory Authority reporting.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Eye disorder, Nausea, Visual impairment
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Systemic: Weakness-Mild, Additional Details: Patient was having eye/visual complaint before administering Pfizer vaccine.  After administering Pfizer vaccine, patient stated she feels dizzy, nauseated, and weakness.  Followed protocol, monitoring patient, advised district leader, and called 911
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site pain, Injection site swelling
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Mild
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Site: Pain at Injection Site-Mild
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Site: Pain at Injection Site-Mild
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Site: Pain at Injection Site-Mild
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Site: Pain at Injection Site-Mild
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Blood test, COVID-19, Chest X-ray normal, Chest pain
Clinical narrative: I was sent to the ER on 10/22/21 for chest pains. My blood pressure and heart rate were elevated- and still remain elevated for my body. I'm on aspirin therapy and I was checked for heart attack and pericarditis. Both were negative. I had lower leg swelling. I continue to have Covid eye and sharp pains in my ears.